Comparative changes of lipid levels in treatment-naive, HIV-1-infected adults treated with dolutegravir vs. efavirenz, raltegravir, and ritonavir-boosted darunavir-based regimens over 48 weeks. | Clin Drug Investig;35(3): 211-9, 2015 Mar. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Comparative changes of lipid levels in treatment-naive, HIV-1-infected adults treated with dolutegravir vs. efavirenz, raltegravir, and ritonavir-boosted darunavir-based regimens over 48 weeks.

Quercia, Romina; Roberts, Jeremy; Martin-Carpenter, Louise; Zala, Carlos.

Affiliation

Quercia R; ViiV Healthcare, Brentford, UK.

Clin Drug Investig ; 35(3): 211-9, 2015 Mar.

Article in En | MEDLINE | ID: mdl-25637061

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Anti-HIV Agents / Lipids Type of study: Guideline / Risk_factors_studies / Systematic_reviews Limits: Adult / Female / Humans / Male Language: En Journal: Clin Drug Investig Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2015 Document type: Article Affiliation country:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Anti-HIV Agents / Lipids Type of study: Guideline / Risk_factors_studies / Systematic_reviews Limits: Adult / Female / Humans / Male Language: En Journal: Clin Drug Investig Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2015 Document type: Article Affiliation country: